HLA-A29.2 subtype associated with birdshot retinochoroidopathy

Area of Science:

• Immunogenetics
• Ophthalmology
• Human Leukocyte Antigen (HLA) research

Background:

• Birdshot retinochoroidopathy (BR) is an inflammatory eye disease.
• The Human Leukocyte Antigen (HLA)-A29 antigen is a known strong genetic risk factor for BR.
• HLA-A29 has subtypes, including HLA-A29.1 and HLA-A29.2, which may influence disease presentation or risk.

Purpose of the Study:

• To investigate the association of HLA-A29 subtypes with birdshot retinochoroidopathy in a French Caucasian population.
• To determine the prevalence of HLA-A29.1 and HLA-A29.2 subtypes in patients with BR.

Main Methods:

• Review of HLA typing data from 58 white French patients diagnosed with birdshot retinochoroidopathy.
• HLA-A29 subtyping was performed using immunoprecipitation followed by one-dimensional electrofocusing gel electrophoresis.
• Statistical analysis to assess the significance of HLA-A29 subtype distribution.

Main Results:

• A high prevalence of HLA-A29 (93.1%) was observed in the patient cohort, with a relative risk of 157.30.
• In a subset of 33 patients, the HLA-A29.2 subtype was found in 100% of cases.
• The absence of the HLA-A29.1 subtype was statistically significant (P < .01) in patients with birdshot retinochoroidopathy.

Conclusions:

• The HLA-A29 antigen is strongly associated with birdshot retinochoroidopathy in this French cohort.
• The specific HLA-A29.2 subtype appears to be a critical genetic factor, potentially protective against the HLA-A29.1 subtype in BR.
• Absence of HLA-A29.1 is a significant finding, suggesting a specific immunogenetic mechanism in birdshot retinochoroidopathy.